Zobrazeno 1 - 7
of 7
pro vyhledávání: '"José-Luis Justicia"'
Publikováno v:
World Allergy Organization Journal, Vol 13, Iss 8, Pp 100346- (2020)
Externí odkaz:
https://doaj.org/article/fd0c774c80314c96af8d5973d9146d56
Publikováno v:
World Allergy Organization Journal, Vol 13, Iss 8, Pp 100346-(2020)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68f0a0364751e88fe120c6f7a24a0b04
https://doi.org/10.1016/j.waojou.2020.100346
https://doi.org/10.1016/j.waojou.2020.100346
Autor:
Concepción Prados, Amparo Solé, José Luis Justicia, Javier de Gracia, Luis Máiz, Esther Quintana-Gallego, Silvia Gartner
Publikováno v:
Expert Review of Respiratory Medicine. 9:183-194
Pulmonary exacerbation (PEx) is a hallmark of cystic fibrosis. Although several criteria have been proposed for the definition of PEx, no consensus has yet been reached. Very often, many PEx cases go unreported. A standardized and validated definitio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bd54bae551971ab7e176deb8de17410
https://doi.org/10.1586/17476348.2015.1016504
https://doi.org/10.1586/17476348.2015.1016504
Autor:
Silvia Scurati, Francesco Marcucci, Hans Jochen Sieber, Cristoforo Incorvaia, Marie David, Liesbeth Ras, José Luis Justicia, Paola Puccinelli, Franco Frati, Tomas Adamec
Publikováno v:
Expert Opinion on Biological Therapy. 9:1207-1215
Specific immunotherapy (IT) is an effective treatment for rhinitis and asthma caused by aeroallergens sensitization. Sublingual IT (SLIT) was introduced to solve the problem of systemic reactions to subcutaneous IT (SCIT) and developed to represent a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2b7fca4b78e3dd003375ee3820152a3
https://doi.org/10.1517/14712590903146869
https://doi.org/10.1517/14712590903146869
Autor:
Agustin Orovitg, M. Cimarra, José-Luis Justicia, Francisco Guerra, Pilar Serrano, Cesarea Sanchez, Víctor Alvà, Carmen Moreno, Laureano Fernández-Távora
Publikováno v:
Annals of Allergy, Asthma & Immunology. 102:247-252
Background Subcutaneous immunotherapy is an etiological therapy for certain IgE-mediated diseases. It is usually administered in 2 phases: induction and maintenance. Administration in clustered schedules during the induction phase may be a valid alte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2afcd877942ce943ecd9742b669c6e20
https://doi.org/10.1016/s1081-1206(10)60088-9
https://doi.org/10.1016/s1081-1206(10)60088-9
Autor:
Víctor Alvà, Luis Navarro, José-Luis Justicia, Alfons Malet, Jeroni Ferrès, Albert Roger, José Luis Eseverri
Publikováno v:
International archives of allergy and immunology. 154(1)
Background: Ultra-rush regimens for administering sublingual immunotherapy to patients with allergies are becoming more widespread. We aimed to assess treatment safety for patients with allergic rhinitis with or without asthma caused by Dermatophagoi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a6c83035915d73f39143fadfc017782
https://pubmed.ncbi.nlm.nih.gov/20664280
https://pubmed.ncbi.nlm.nih.gov/20664280